Multiple genetic aberrations in the regulation of BCL6, including in acetyltransferase genes, occur in clinically aggressive B-cell lymphomas and lead to higher expression levels and activity of this transcriptional repressor. This evidence concerns the gene BCL6 and B-cell non-Hodgkin lymphoma.